Abstract
A Phase-Ib/II Clinical Evaluation of Ponatinib in Combination with Azacitidine in FLT3-ITD and CBL-Mutant Acute Myeloid Leukemia (PON-AZA study)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have